Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method

Drug, Healthcare and Patient Safety · Published 2026-01-01 · DOI 10.2147/dhps.s556918

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/dhps.s556918

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles